Keyphrases
HIV Infection
100%
CD4 T Cells
100%
Vaccine Vector
100%
HIV Vaccine
100%
ALVAC
64%
Adenovirus Type 5
50%
HIV Susceptibility
28%
Vaccination
21%
CD8+ T Cells
21%
RV144
14%
Vaccine Trial
7%
Host Response
7%
Proliferative Response
7%
Carbon Tetrachloride
7%
C-C Chemokine Receptor Type 5 (CCR5)
7%
HIV Entry
7%
C-X-C Chemokine Receptor Type 4 (CXCR4)
7%
Viral Vectors
7%
Co-receptor
7%
T Cell Proliferation
7%
Phenotypic Analysis
7%
Interleukin-17 (IL-17)
7%
MIP-1b
7%
Surface Expression
7%
Thai
7%
CD-8
7%
Human Adenovirus Type 5
7%
Canarypox
7%
Immunology and Microbiology
Human Immunodeficiency Virus Infection
100%
T-Helper Cell
100%
HIV Vaccine
100%
Human Immunodeficiency Virus
78%
Human Adenovirus 5
57%
Cytotoxic T-Cell
21%
T Cell Proliferation
14%
RV 144
14%
Immune Response
7%
Chemokine Receptor CCR5
7%
Chemokine Receptor CXCR4
7%
Viral Vector
7%
CD8
7%
Interleukin 17
7%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
T Cell
100%
CD4
100%
Human Adenovirus 5
47%
CD8
23%
Cell Proliferation
11%
Clinical Trial
5%
CXCR4
5%
CCR5
5%
Immune Response
5%
Virus Vector
5%
Co-Receptor
5%
CCL4
5%
Interleukin 17
5%